Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Related Posts AF2 Capital Corp. Enters into Letter of Intent for Reverse-Takeover Transaction with EverKind Inc. October 17, 2025 Tactical Resources Provides Rare Earths Business Update in Advance of Nasdaq Listing October 17, 2025 AFDG via Butembo Acquisition Becomes First US Public Company in the Democratic Republic of the Congo (DRC) October 17, 2025
AF2 Capital Corp. Enters into Letter of Intent for Reverse-Takeover Transaction with EverKind Inc. October 17, 2025
Tactical Resources Provides Rare Earths Business Update in Advance of Nasdaq Listing October 17, 2025
AFDG via Butembo Acquisition Becomes First US Public Company in the Democratic Republic of the Congo (DRC) October 17, 2025